Jean Charles Dalphin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean Charles Dalphin has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Degano
University of Grenoble Alpes, INSERM, CHU Grenoble Alpes
18 shared publications A. Guillien
Service d’explorations fonctionnelles de la respiration, de l’exercice et de la dyspnée, hôpital Jean-Minjoz, 2, boulevard Fleming, 25030 Besançon cedex, Besançon, France
9 shared publicationsJ.J. Laplante
7 shared publications- Alain Depierre
CHU de Besançon, Université de Franche-Comté, Besançon, France
6 shared publications - Jean-Claude Pairon
Equipe GEIC20, INSERM U955, 94000 Créteil, France
6 shared publications - Thibaud Soumagne
Service de pneumologie et soins intensifs, Hôpital Européen Georges Pompidou, AP-HP Centre-Université Paris Cité, Paris, France
6 shared publications
Latest Publications
- 1 December 2019
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 36 (10) , 1083-1087
La pollution atmosphérique et ses effets sur la santé respiratoire : les experts du groupe PAPPEI répondent au Bureau de la SPLF
- 1 December 2019
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 36 (10) , 1083-1087
La pollution atmosphérique et ses effets sur la santé respiratoire : les experts du groupe PAPPEI répondent au Bureau de la SPLF
- Open Access
- 17 June 2019
- Published by Springer Nature in Respiratory Research
- Vol. 20 (1) , 1-8
Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?
Allergic mechanisms related to environmental and occupational exposure have been suggested to contribute to the development of chronic obstructive pulmonary disease (COPD). To investigate the relationships between atopy markers, persistent airflow limitation (PAL) and occupational exposure in dairy farmers. Clinical and biological (total IgE and 21 allergen specific IgE) markers of atopy were assessed in 101 dairy farmers with PAL (DF-PAL), 85 non-farmers with PAL (NF-PAL) (both groups were prospectively included from a screening program performed between 2011 and 2015), and matched controls, i.e. 98 farmers without PAL (DF-controls) and 89 non-farming subjects without PAL (NF-controls). Occupational exposure in farmers was estimated using a validated questionnaire. Prevalence of allergy history was significantly higher in DF-PAL and in NF-PAL than in controls. Polysensitization, and sensitization to seasonal and food allergens were more frequent in DF-PAL than in DF-controls, respectively: 13.8% vs 1% (adjusted odds ratio (aOR): 17.5 (2.2–134), 11.9% vs 3.1% (aOR: 4.4 (1.2–7.2) and 16.8% vs 4.1% (aOR: 5.2 (1.7–7.2)). The prevalence of atopy markers was similar between NF-PAL patients and NF-controls. PAL in farmers is associated with a high rate of markers of atopy, supporting atopy as a risk indicator. Clinical trial registered with ClinicalTrials.gov (NCT02540408).
- 17 June 2019
- Published by Springer Nature in Respiratory Research
- Vol. 20 (1) , 1-8
Open AccessIs atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?
Allergic mechanisms related to environmental and occupational exposure have been suggested to contribute to the development of chronic obstructive pulmonary disease (COPD). To investigate the relationships between atopy markers, persistent airflow limitation (PAL) and occupational exposure in dairy farmers. Clinical and biological (total IgE and 21 allergen specific IgE) markers of atopy were assessed in 101 dairy farmers with PAL (DF-PAL), 85 non-farmers with PAL (NF-PAL) (both groups were prospectively included from a screening program performed between 2011 and 2015), and matched controls, i.e. 98 farmers without PAL (DF-controls) and 89 non-farming subjects without PAL (NF-controls). Occupational exposure in farmers was estimated using a validated questionnaire. Prevalence of allergy history was significantly higher in DF-PAL and in NF-PAL than in controls. Polysensitization, and sensitization to seasonal and food allergens were more frequent in DF-PAL than in DF-controls, respectively: 13.8% vs 1% (adjusted odds ratio (aOR): 17.5 (2.2–134), 11.9% vs 3.1% (aOR: 4.4 (1.2–7.2) and 16.8% vs 4.1% (aOR: 5.2 (1.7–7.2)). The prevalence of atopy markers was similar between NF-PAL patients and NF-controls. PAL in farmers is associated with a high rate of markers of atopy, supporting atopy as a risk indicator. Clinical trial registered with ClinicalTrials.gov (NCT02540408).
- 1 April 2019
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 36 (4) , 495-507
Pneumopathie d’hypersensibilité de l’enfant
- 1 April 2019
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 36 (4) , 495-507
Pneumopathie d’hypersensibilité de l’enfant
- Open Access
- 11 January 2019
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 19 (1) , 4
How spontaneous pneumothorax is managed in emergency departments: a French multicentre descriptive study
Management of spontaneous pneumothorax (SP) is still subject to debate. Although encouraging results of recent studies about outpatient management with chest drains fitted with a one-way valve, no data exist concerning application of this strategy in real life conditions. We assessed how SP are managed in Emergency departments (EDs), in particular the role of outpatient management, the types of interventions and the specialty of the physicians who perform these interventions. From June 2009 to May 2013, all cases of spontaneous primary (PSP) and spontaneous secondary pneumothorax (SSP) from EDs of 14 hospitals in France were retrospectively included. First line treatment (observation, aspiration, thoracic drainage or surgery), type of management (admitted, discharged to home directly from the ED, outpatient management) and the specialty of the physicians were collected from the medical files of the ED. Among 1868 SP included, an outpatient management strategy was chosen in 179 PSP (10%) and 38 SSP (2%), mostly when no intervention was performed. Only 25 PSP (1%) were treated by aspiration and discharged to home after ED admission. Observation was the chosen strategy for 985 patients (53%). In 883 patients with an intervention (47%), it was performed by emergency physicians in 71% of cases and thoracic drainage was the most frequent choice (670 patients, 76%). Our study showed the low level of implementation of outpatient management for PS in France. Despite encouraging results of studies concerning outpatient management, chest tube drainage and hospitalization remain preponderant in the treatment of SP.
- 11 January 2019
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 19 (1) , 4
Open AccessHow spontaneous pneumothorax is managed in emergency departments: a French multicentre descriptive study
Management of spontaneous pneumothorax (SP) is still subject to debate. Although encouraging results of recent studies about outpatient management with chest drains fitted with a one-way valve, no data exist concerning application of this strategy in real life conditions. We assessed how SP are managed in Emergency departments (EDs), in particular the role of outpatient management, the types of interventions and the specialty of the physicians who perform these interventions. From June 2009 to May 2013, all cases of spontaneous primary (PSP) and spontaneous secondary pneumothorax (SSP) from EDs of 14 hospitals in France were retrospectively included. First line treatment (observation, aspiration, thoracic drainage or surgery), type of management (admitted, discharged to home directly from the ED, outpatient management) and the specialty of the physicians were collected from the medical files of the ED. Among 1868 SP included, an outpatient management strategy was chosen in 179 PSP (10%) and 38 SSP (2%), mostly when no intervention was performed. Only 25 PSP (1%) were treated by aspiration and discharged to home after ED admission. Observation was the chosen strategy for 985 patients (53%). In 883 patients with an intervention (47%), it was performed by emergency physicians in 71% of cases and thoracic drainage was the most frequent choice (670 patients, 76%). Our study showed the low level of implementation of outpatient management for PS in France. Despite encouraging results of studies concerning outpatient management, chest tube drainage and hospitalization remain preponderant in the treatment of SP.
- 11 May 2018
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 12 (6) , 493-507
Current and emerging techniques for the diagnosis of hypersensitivity pneumonitis
Introduction: Hypersensitivity pneumonitis (HP) is the result of an immunologically induced inflammation of the lung parenchyma in response to inhalation exposure to a large variety of antigens in genetically susceptible individuals. HP shares clinical and radiological features with other acute and chronic interstitial lung diseases and is sometimes difficult to diagnose if exposure to an antigenic agent is not detected. Several classifications and diagnostic criteria have been proposed but are not currently recommended by guidelines from any scientific society. However, advances have been made over the past ten years in improving the diagnosis of HP. Areas covered: This article will provide a summary of the different classification and diagnostic criteria proposed in acute and chronic forms of HP. In addition, we review current diagnostic procedures including antigen detection, high resolution computed tomography, histopathology and provide an overview of emerging techniques. Expert commentary: Important changes are occurring in the field of HP and knowledge of the disease will likely progress enormously in the coming 5 to 10 years as many techniques continue to be developed, including genomic signature and diagnostic biomarkers.
- 11 May 2018
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 12 (6) , 493-507
Current and emerging techniques for the diagnosis of hypersensitivity pneumonitis
Introduction: Hypersensitivity pneumonitis (HP) is the result of an immunologically induced inflammation of the lung parenchyma in response to inhalation exposure to a large variety of antigens in genetically susceptible individuals. HP shares clinical and radiological features with other acute and chronic interstitial lung diseases and is sometimes difficult to diagnose if exposure to an antigenic agent is not detected. Several classifications and diagnostic criteria have been proposed but are not currently recommended by guidelines from any scientific society. However, advances have been made over the past ten years in improving the diagnosis of HP. Areas covered: This article will provide a summary of the different classification and diagnostic criteria proposed in acute and chronic forms of HP. In addition, we review current diagnostic procedures including antigen detection, high resolution computed tomography, histopathology and provide an overview of emerging techniques. Expert commentary: Important changes are occurring in the field of HP and knowledge of the disease will likely progress enormously in the coming 5 to 10 years as many techniques continue to be developed, including genomic signature and diagnostic biomarkers.
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A200
Rôle du régime alimentaire dans le développement de la BPCO chez des sujets non-fumeurs exposés à des poussières organiques
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A200
Rôle du régime alimentaire dans le développement de la BPCO chez des sujets non-fumeurs exposés à des poussières organiques
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A168
Anxiété et dépression chez les producteurs laitiers BPCO
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A168
Anxiété et dépression chez les producteurs laitiers BPCO
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A154
Prise en charge des pneumothorax : étude de cas chez des patients fumeurs de cannabis
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A154
Prise en charge des pneumothorax : étude de cas chez des patients fumeurs de cannabis
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A66-A67
La résolution de l’inflammation dans la fibrose pulmonaire idiopathique avec un nouvel immunomodulateur
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A66-A67
La résolution de l’inflammation dans la fibrose pulmonaire idiopathique avec un nouvel immunomodulateur
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A64
Prévalence et caractéristique de l’emphysème dans la maladie de poumon de fermier : une étude prospective
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A64
Prévalence et caractéristique de l’emphysème dans la maladie de poumon de fermier : une étude prospective